https://www.selleckchem.com/pr....oducts/CGS-21680-hyd
5% ± 3.1% at 10years and 86.4% ± 6.2% at 30years. Freedom from aortic valve re-operation was higher (p 0.001) in the mechanical AVR than in the biological AVR cohort with 95.2% ± 4.6% and 33.6% ± 13.4% freedom from re-operation at 10years respectively. Re-operation was less frequent in the mechanical AVR cohort than in the biological AVR cohort. For mechanical AVR, the risk for thromboembolic and bleeding events was considerable with a composite linearized event rate per valve-year of 3.2%. Re-operation was less fre